FDA Class I drug recalls
This page indexes the U.S. FDA drug recalls that the agency has classified as Class I. It is a regulatory finding aid, not medical advice.
What "Class I" means as a regulatory classification
Class I is the most serious of the three classifications the FDA uses when it records a drug recall in its enforcement reports. The classification is the agency's own categorisation of the recall event within its regulatory framework. It is assigned by the FDA, captured as a field in the enforcement report, and reproduced here exactly as the source states it. On this site the label carries no meaning beyond that administrative one: it is not a personalised risk score, not a clinical judgement, and not a statement about how any individual should act.
Because Class I is the agency's highest-priority recall category, these records are often the ones that regulatory-affairs and quality-assurance teams want to locate first when they scan the enforcement reporting stream. Distributors and procurement teams may track Class I actions to understand which marketed products have been the subject of the agency's most serious recall tier over a given window. The value of indexing them here is simply speed of retrieval and ease of dating and cross-referencing — every entry links straight back to the verifiable openFDA source so the official record can be confirmed.
How to read the Class I list
The table below lists the Class I recall records currently in the indexed dataset, newest first by report date. Each row links to a dedicated record page that lays out the product description, the recalling firm, the firm's stated reason for the recall, the distribution pattern, the geographic fields, and the relevant dates — all as regulatory data points drawn from the enforcement report. From each record page you can follow a link to the official openFDA query that returns the source report.
Two cautions are worth repeating. First, the presence of a product in this list reflects a regulatory action recorded by the FDA; it is an administrative fact and not a verdict on a company or a clinical warning to any person. Second, the list reflects what had been ingested at the most recent pipeline run, which can lag the live FDA record. For any decision, confirm the current status against the official source.
What each Class I record contains
Every Class I record page on this site lays out the same regulatory fields, drawn directly from the FDA enforcement report. The recall number and event identifier let you tie the entry back to the agency's own systems and to other recall lines that share the same event. The product description records the item as the firm characterised it. The recalling firm is the company that initiated or conducted the action. The firm's stated reason is reproduced verbatim as a data field — it explains, in the firm's words, why the recall was undertaken, and it is presented for identification only rather than as any kind of instruction. The distribution pattern describes how widely the product was distributed, and the state and country fields locate the firm. Finally, a set of dates — report date, recall initiation date and, where applicable, termination date — lets you place the action precisely in time.
Presenting these fields consistently is what turns a stream of individual enforcement reports into something you can scan, sort and compare. But the consistency is purely structural: it organises the regulator's data without adding interpretation. Nothing on a Class I record page assesses risk to any individual, recommends a course of action, or makes a clinical claim. The classification itself is the FDA's, the field values are the FDA's, and the role of this page is only to surface them clearly and link you straight back to the authoritative source.
Related recall views
Class I recalls are one of three regulatory tiers. You can also review Class II recalls and Class III recalls, or return to the drug recalls hub for the full explanation of how recall classifications and statuses are defined. To understand the terminology used across these pages, see the regulatory intelligence glossary, and for the data lineage see the methodology and FDA data sources pages.
Source & provenance
- Official source
- https://open.fda.gov/apis/drug/enforcement/
- Source dataset
- openFDA Drug Enforcement API
- Publication date
- Not available
- Ingested
- 2026-06-09
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.